Navigating liver disease complexity: Innovations in in vitro modeling and precision medicine
- PMID: 38088881
- DOI: 10.1097/HEP.0000000000000719
Navigating liver disease complexity: Innovations in in vitro modeling and precision medicine
Comment on
-
A multicellular liver organoid model for investigating hepatitis C virus infection and nonalcoholic fatty liver disease progression.Hepatology. 2024 Jul 1;80(1):186-201. doi: 10.1097/HEP.0000000000000683. Epub 2023 Nov 16. Hepatology. 2024. PMID: 37976400
References
-
- Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18:2650–66.
-
- Nuciforo S, Heim MH. Organoids to model liver disease. JHEP Reports. 2021;3:100198.
-
- Van Norman GA. Limitations of animal studies for predicting toxicity in clinical trials. JACC Basic to Transl Sci. 2019;4:845–54.
-
- Mun SJ, Ryu JS, Lee MO, Son YS, Oh SJ, Cho HS, et al. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. J Hepatol. 2019;71:970–85.
-
- Nie YZ, Zheng YW, Miyakawa K, Murata S, Zhang RR, Sekine K, et al. Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells. EBioMedicine. 2018;35:114–23.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical